Stelara 90 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FQPV8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,584
Award facts
- Contract value 100% obligated
- $16,584.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,584.13 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. The award, issued on December 8, 2025, with an ultimate completion date of December 30, 2025, carries no set-aside designation, indicating the vendor competed in open procurement. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) established through the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499,999,999 ceiling value and completion date of December 31, 2036.
The PPV-G GEN V represents a comprehensive $30.3 billion acquisition strategy designed to support the Department of Defense's pharmaceutical supply requirements across military healthcare facilities worldwide. As a regional prime vendor contractor under this program, DMS Pharmaceutical Group serves as a critical supplier for both branded and generic pharmaceutical products, biologics, and medical consumables to federal military medical systems. The vendor's established performance history on numerous prior delivery orders ranging from under $100 to over $115,000 demonstrates its capability to fulfill the specialized and diverse pharmaceutical needs of DoD healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FQPV8?
SPE2DR26FQPV8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26FQPV8 worth?
The government has obligated $16,584 on SPE2DR26FQPV8.
Is contract SPE2DR26FQPV8 an order under another contract?
Yes. SPE2DR26FQPV8 is a delivery order under SPE2DR25D9331, an indefinite delivery contract.
Was contract SPE2DR26FQPV8 competed?
The extent of competition for SPE2DR26FQPV8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award